Aileron Therapeutics Stock Price, News & Analysis
Company Description
Aileron Therapeutics (NASDAQ: ALRN) is a publicly traded pharmaceutical preparation manufacturing company in the Pharmaceutical Preparations sector. The company has a market capitalization of $45.7M, ranking #5,689 among all listed U.S. companies by market cap.
ALRN stock has declined 43.0% over the past year. Shares last traded at $2.11.
This page provides a comprehensive overview of ALRN stock, including real-time price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.
Stock Performance
Aileron Therapeutics (ALRN) stock last traded at $2.11. Over the past 12 months, the stock has lost 43.0%. At a market capitalization of $45.7M, ALRN is classified as a micro-cap stock with approximately 21.7M shares outstanding.
Latest News
Aileron Therapeutics has 10 recent news articles. Of the recent coverage, 4 articles coincided with positive price movement and 6 with negative movement. Key topics include earnings, clinical trial, acquisition, conferences. View all ALRN news →
SEC Filings
Financial Highlights
Upcoming Events
Short Interest History
Days to Cover History
ALRN Company Profile & Sector Positioning
Aileron Therapeutics (ALRN) operates in the Pharmaceutical Preparation Manufacturing industry within the broader Pharmaceutical Preparations sector and is listed on the NASDAQ.